Frailty, Nutrition, and Recovery in People Waiting for a Liver Transplant
Official title: Investigation of the Relationship Between Frailty, Sarcopenia, Malnutrition, and Psychosocial Parameters and Post-Transplant Outcomes in Liver Transplant Candidates
Run by Izmir Bakircay University · NCT07414095 · Data updated 2026-11-12
This project will test whether measures of frailty, muscle loss, nutrition, and psychological health can predict outcomes for adults (18–65) on the liver transplant waiting list in Turkey.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Izmir Bakircay University Academic / other |
| Locations | 1 site (Izmir) |
| Status | Recruiting |
| Started | December 15, 2025 |
| Main results expected | August 2026 |
| Study ends | August 2026 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT07414095 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18–65 who are listed for liver transplant at the participating center and can understand Turkish and complete simple physical tests.
✕Probably not a fit
Patients with severe orthopedic or neurological limitations, active serious extrahepatic malignancy, multiple organ transplants, or inability to follow verbal commands may not benefit from the assessments.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study enrolls adults listed for liver transplant and collects simple physical tests (strength, walking speed, daily activity), nutrition measures, and psychological screening before transplant. Researchers will link these multidimensional measures to clinical liver scores and track outcomes after transplant such as length of stay, complications, and survival. The design is longitudinal and descriptive, using routine clinical follow-up to relate pre-transplant status to post-transplant recovery. Findings aim to identify high-risk patients who might benefit from targeted pre- and post-transplant support.
Why it matters
Potential benefit: If successful, the findings could help clinicians identify patients at higher risk and tailor nutrition, physical therapy, and psychosocial support to improve recovery and survival.
How similar studies have gone: Previous observational studies have shown that frailty and sarcopenia predict worse outcomes after liver transplant, so this approach builds on existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being listed as a liver transplant candidate * Age between 18 and 65 years * Ability to understand the Turkish language Exclusion Criteria: * Presence of orthopedic and/or neurological problems severe enough to prevent completion of assessment tools * Inability to understand verbal commands * Being a recipient of multiple organ transplants * Presence of serious active extrahepatic malignancy
Where it's running
-
Izmir University of Economics Medical Point Hospital
Izmir, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Assistant Professor
- Email: ayse.vatansever@bakircay.edu.tr
- Phone: 14046
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Even protein distribution plus exercise for people awaiting liver transplant
This trial tests whether spreading daily protein evenly and combining it with a 12-week exercise program improves nutrition, muscle mass, and function in people waiting for a liver transplant compared with uneven protein timing or usual advice.
-
Preoperative Carbohydrate Loading Before Liver Transplant
This study tests whether drinking a carbohydrate beverage before anesthesia helps liver transplant patients recover faster.
-
Train the immune system to accept a living-donor liver so you may stop lifelong anti-rejection drugs
This test gives donor stem cells plus a short conditioning treatment to people with HLA-matched living-donor liver transplants to see if they can safely stop long-term immunosuppressive drugs.
-
Exploring muscle composition's impact on liver transplant outcomes
This study is testing how muscle health affects the success of liver transplants in patients with severe liver disease.
-
Hepatology home hospital program for people with advanced liver disease
This will try a hospital-at-home program that brings hepatology care to adults with cirrhosis who would otherwise need inpatient care.
-
Endovascular treatment outcomes after portal hypertension–related GI bleeding in cirrhosis
This study tests how well endovascular procedures for portal hypertension–related GI bleeding work in adults with cirrhosis, and what factors predict outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.